Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct 11:7:21.
doi: 10.4103/1742-6413.70968.

Determination of HER-2 status on FNAC material from breast carcinomas using in situ hybridization with dual chromogen visualization with silver enhancement (dual SISH)

Elsa Beraki  1 , Torill Sauer
Affiliations

Determination of HER-2 status on FNAC material from breast carcinomas using in situ hybridization with dual chromogen visualization with silver enhancement (dual SISH)

Elsa Beraki et al. Cytojournal. .

Abstract

During the last years, HER-2 status kits and protocols for chromogen visualization of hybridization signals have come on the market. The first generation using chromogen visualization used single color probes. The second generation, now emerging on the market, uses dual chromogen visualization. The aim of this study has been to test a new dual color chromogen kit (Ventana INFORM HER2 Dual Colour ISH Roche(®)) and compare the results with our in-house method(s). The material consisted primarily of cytological material from invasive breast carcinomas in 49 women. Dual SISH was done on all 49 cytological and histological specimens. The histological specimens were treated according to the manufacturer's recommendations. The procedure was modified in several steps in order to adapt it to the cytological material. Hybridization failed in two cytological specimens. Dual SISH showed concordant results on cytological and histological material as to amplified/not amplified. The included cases had the same HER-2 expression in the invasive and the in situ components on histology. Four IDC showed HER-2 amplification (8.5%). Polysomy was found in two cases. All dual SISH results except for one concurred with the results of the in-house method(s) (1/47=2.1%). The dual SISH is suitable for cytological examination of HER-2 status. The protocol must be optimized for cytological material.

Keywords: Breast carcinoma; HER-2; dual SISH; fine needle aspiration cytology; in situ hybridization; liquid based material.

PubMed Disclaimer

Figures

Figure 1a
Figure 1a
Dual color SISH. Magnification × 1000. Cytological specimen, direct smear. Non-amplified with two signals of CEP17 (red) and HER-2 gene (black) per nucleus
Figure 1b
Figure 1b
Dual color SISH. Magnification × 1000. Histological specimen. Non-amplified with two signals of CEP17 (red) and HER-2 gene (black) per nucleus
Figure 2a
Figure 2a
Dual color SISH. Magnification × 1000. Cytological specimen, liquid based preparation. Two CEP17 (red) signals and from 5 to > 10 HER-2 gene signals (black) per nucleus. Amplification.
Figure 2b
Figure 2b
Dual color SISH. Magnification × 1000. Histological specimen. Two CEP17 (red) signals and a highly increased number of HER-2 gene signals (black) per nucleus. Amplification.
Figure 3
Figure 3
Dual color SISH. Magnification × 1000. Cytological specimen. Liquid based preparation. Polysomy with increased number of both CEP17 (red) and HER-2 gene (black) per nucleus
See this image and copyright information in PMC

References

    1. NBCG. Blåboka. Oslo, Norwegian Breast Cancer Group. 2007
    1. Sosialdirektoratet H-o. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av pasienter med brystkreft. In “Nasjonale faglige retningslinjer 15-1524”. 2007 (National action program and recommendations for diagnostics, treatment and follow-up of patients with breast cancer)
    1. Kocjan G. The role of breast FNAC in diagnosis and clinical management: A survey of current practice. Cytopathology. 2008;19:271–8. - PubMed
    1. Kevin CH, Benjamin RK. Fluorescence in situ hybridization in diagnostic cytology. Hum Pathol. 2007;38:1137–44. - PubMed
    1. Kim GY, Oh YL. Chromogenic in situ hybridization analysis of HER-2/neu status in cytological samples of breast carcinoma. Cytopathology. 2004;15:315–20. - PubMed